(±)-trans-2-[3-Methoxy-4-(4-chlorophenylthioethoxy)-5-(N-methyl-N- hydroxyureidyl)methylphenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (CMI-392), a Potent Dual 5-Lipoxygenase Inhibitor and Platelet-Activating Factor Receptor Antagonist
- 29 April 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (11), 1970-1979
- https://doi.org/10.1021/jm980046r
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The Role of Leukotrienes in InflammationAnnals of Internal Medicine, 1994
- Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3-hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterJournal of Medicinal Chemistry, 1992
- 5-Lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitorsJournal of Medicinal Chemistry, 1992
- Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole bloodex vivoInflammation Research, 1991
- Severe Streptococcal Axillary LymphadenitisNew England Journal of Medicine, 1990
- Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agentsInflammation Research, 1985
- Chemical and biochemical aspects of platelet activating factor: A novel class of acetylated ether‐linked choline‐phospholipidsMedicinal Research Reviews, 1985
- Platelet-activating factor: An effector substance of the vasopermeability changes induced by the infusion of immune aggregates in the mouseImmunopharmacology, 1983
- Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme MarkerJournal of Investigative Dermatology, 1982
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980